Tachycardia preconditions infarct size in dogs: Role of adenosine and protein kinase C

Circulation

Volumn 97, Issue 8, 1998, Pages 786-794

  Domenech, Raúl J ^a   Macho, Pilar ^a   Vélez, Diego ^a   Sánchez, Gina ^a   Liu, Xueliang ^b   Dhalla, Naranjan ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adenosine; Myocardial infarction; Preconditioning; Protein kinase C

Indexed keywords

ADENOSINE; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CORONARY ARTERY; DOG; ELECTROCARDIOGRAM; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART RATE; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA;

EID: 0032478164     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.8.786     Document Type: Article

References (47)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74: 1124-1136.
2. Przyklenk K, Kloner RA, Whittaker P. Synopsis of ischemic preconditioning: what have we learned since 1986? In: Przyklenk K, KJoner RA, Yellon DR, eds. Ischemic Preconditioning: the Concept of Endogenous Cardioproteciion. Boston/Dordrecht/London: Kluwer Academic Publishers; 1994; 153-170.
3. Koning MMG, Gho BCG, van Klaarwater E, Opstal RLJ, Duncker DJ, Verdouw PD. Rapid ventricular pacing produces myocardial protection by nonischemic activation of ATP potassium channels. Circulation. 1996;93: 178-186.
4. ATP channels, and ischemic preconditioning in dogs. Am J Physiol. 1993;264:H1327-H1336.
5. Saito D, Nixon DG, Vomacka RB, Olsson RA. Relationship of cardiac oxygen usage, adenosine content, and coronary resistance in dogs. Circ Res. 1980;47:875-882.
6. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;18:565-574.
7. Watkinson WP, Foley DH, Rubio R, Berne RM. Myocardial adenosine formation with increased cardiac performance in the dog. Am J Physiol. 1979;236:H13-H21.
8. McKenzie JE, McCoy FP, Bockman EL. Myocardial adenosine and coronary resistance during increased cardiac performance. Am J Physiol. 1980; 8:H509-H515.
9. Steiner C, Kovalic ATW. A simple technique fur production of chronic complete heart block in dog. J Appl Physiol. 1968;25:631-633.
10. Van Wylen DGL, Willis JSJ, Weiss RJ, Lasley RD, Mentzer RM Jr. Cardiac microdialysis to measure interstitial adenosine and coronary blood flow. Am J Physiol. 1990;259:H1642-H1648.
11. Domencch RJ, Macho P, Gonzalez R, Huidobro-Toro JP. Effect of endothelin on total and regional coronary resistance and on myocardial contractility. Eur J Pharmacol. 1991;192:409-416.
12. Buckberg GD, Luck JC, Payne DB, Huffman JIE, Archie JP, Fixier DE. Some sources of error in measuring regional flow with radioactive microspheres, J Appl Physiol. 1971;31:598-604.
13. Tanaka Y, Kashiwagi A, Ogawa T, Abe T, Asahina T, Ikebuchi M, Takagi Y, Shigeta Y. Effect of verapamil on cardiac protein kinase C activity in diabetic rats. Eur J Pharmocol. 1991;200:353-356.
14. Okumura K, Akiyama N, Hashimoto H, Ogawa K, Satake T. Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes. 1988;37:1168-1172.
15. Nagy K, Levy J, Grunberg G. Impaired translocation of protein kinase C activity in human non-insulin-dependent diabetes mellitus. Metabolism. 1991;40:807-813.
16. Braconi S, Church DJ, Vallotton MB, Lang U. Functional inhibition of protein kinase C-mediated effects in myocardial tissue is due to the phosphatase 2A. Biochem J. 1992;286:851-855.
17. Hescheler J, Mieskes G, Regg JC, Takai A, Trautwein W. Effect of a protein phosphause inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflugers Arch. 1988;412:248-252.
18. Bialojan C, Takai A, Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases: specificity and kinetics. Biochem J. 1988;256: 283-290.
19. Xung H, McNeill JH. Protein kinase C activity is altered in diabetic rat hearts. Biochem Biophys Res Commun. 1992;187:703-710.
20. Gu X, Bishop SP. Increased protein kiruse C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res. 1994;75: 926-931.
21. Bache RJ, Cobb FR. Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res. 1977;41:648-653.
22. Domenech RJ, Goich J. Effect of heart rate on regional coronary blood flow. Cardiovasc Res. 1976;10:224-231.
23. Becker L. Effect of tachycardia on left ventricular blood flow distribution during coronary occlusion. Am J Physiol. 1976;230:1072-1077.
24. Brazier JR, Buckberg GD. Effects of tachycardia on the adequacy of subendocardial oxygen delivery in experimental aortic stenosis. Am Heart J. 1975;90:222-230.
25. Buckberg GD, Fixier DE, Archie JP, Henney RP, Hoffman JIE. Variable effects of heart rate on phasic and regional left ventricular muscle blood flow in anaesthetized dogs. Cardiovasc Res. 1975;9:1-11.
26. Khouri EM, Gregg DE, Rayford CR. Effect of exercise on cardiac output, left coronary flow and myocardial metabolism in the unanesthetized dog. Circ Res. 1965;17:427-433.
27. Lochner W, Nasseri M. Uber den venöseen sauerstoffdruck, die einstellung der coronardurchbluting und den kohlenhydratstoffwechsel des herzens bei muskelarbeit. Pflugers Arch. 1959;269:407-416.
28. Restorff W, Holtz J, Bassenge E. Exercise induced augmentation of myocardial oxygen extraction in spite of normal coronary dilatory capacity in dogs. Pflugers Arch. 1977;372:181-185.
29. Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol. 1994;266:H137-H146.
30. Szekeres L, Papp JG, Szilvassy Z, Udvary E, Vegh A. Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res. 1993;27:593-596.
31. Vegh A, Szekeres L, Parrat JR. Transient ischemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res. 1991;25: 1051-1053.
32. Vegh A, Komori S, Szekeres L, Parrat JR. Antiarrhythmic effects of preconditioning in anaesthetized dogs and rats. Cardiovasc Res. 1992;26: 487-495.
33. Przyklenk K, Kloner RA. Preconditioning does not attenuate ventricular ectopy in the canine model. J Mol Cell Cardiol. 1994;26:137. Abstract.
34. Thomton JD, Thomton CS, Downey JM. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am J Physiol. 1993;265:H504-H508.
35. Hall JL, Vin Wylen DGL, Pizzurro RD, Hamilton CD, Reiling CM, Stanley WC. Myocardial interstitial purine metabolites and lactate with increased work in swine. Cardiovasc Res. 1995;30:351-356.
36. Londos C, Cooper DMF, Schlegel W, Rodbell M. Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci U S A.. 1978;75:5362-5366.
37. Niroomand F, Weinbrenner C, Weis A, Bangert M, Schwencke C, Marquetant R, Beyer T, Strasser RH, Kübier W, Rauch B. Impaired function of inhibitory G proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia. Cric Res. 1995;76:861-870.
38. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 1986;251:H1306-H1315.
39. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66:913-931.
40. Jennings RB, Murry CE, Reimer KA. Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol. 1991;23:1449-1458.
41. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mon H, Inoue M, Hori M, Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation. 1996;93: 781-791.
42. Bankwala Z, Hale SL, Kloner RA, α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation. 1994;90:1023-1028.
43. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res. 1994;75:576-585.
44. Blombery PA, Heinzow BG. Cardiac and pulmonary norepinephrine release and removal in the dog. Circ Res. 1983;53:688-694.
45. Przyklenk K. Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 1995;92:1546-1557.
46. Ytrehus K, Liu Y, Downey JM. Preconditioning protects the ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266: H1145-H1152.
47. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in the rat heart? Am J Physiol. 1995;268:H426-H431.